Retension Pharmaceuticals Appoints Robert Wong Chief Accounting Officer
Robert Wong will become vice president and chief accounting officer effective November 2, 2026. The company also entered into an offer letter outlining his compensation.
Robert Wong will become vice president and chief accounting officer effective November 2, 2026. The company also entered into an offer letter outlining his compensation.